1
|
Miglietta S, Cristiano L, Battaglione E, Macchiarelli G, Nottola SA, De Marco MP, Costanzi F, Schimberni M, Colacurci N, Caserta D, Familiari G. Heavy Metals in Follicular Fluid Affect the Ultrastructure of the Human Mature Cumulus-Oocyte Complex. Cells 2023; 12:2577. [PMID: 37947655 PMCID: PMC10650507 DOI: 10.3390/cells12212577] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Revised: 10/30/2023] [Accepted: 10/31/2023] [Indexed: 11/12/2023] Open
Abstract
It is known that exposure to heavy metal such as lead (Pb) and cadmium (Cd) has several adverse effects, particularly on the human reproductive system. Pb and Cd have been associated with infertility in both men and women. In pregnant women, they have been associated with spontaneous abortion, preterm birth, and impairment of the development of the fetus. Since these heavy metals come from both natural and anthropogenic activities and their harmful effects have been observed even at low levels of exposure, exposure to them remains a public health issue, especially for the reproductive system. Given this, the present study aimed to investigate the potential reproductive effects of Pb and Cd levels in the follicular fluid (FF) of infertile women and non-smokers exposed to heavy metals for professional reasons or as a result of living in rural areas near landfills and waste disposal areas in order to correlate the intrafollicular presence of these metals with possible alterations in the ultrastructure of human cumulus-oocyte complexes (COCs), which are probably responsible for infertility. Blood and FF metals were measured using atomic absorption spectrometry. COCs corresponding to each FF analyzed were subjected to ultrastructural analyses using transmission electron microscopy. We demonstrated for the first time that intrafollicular levels of Pb (0.66 µg/dL-0.85 µg/dL) and Cd (0.26 µg/L-0.41 µg/L) could be associated with morphological alterations of both the oocyte and cumulus cells' (CCs) ultrastructure. Since blood Cd levels (0.54 µg/L-1.87 µg/L) were above the current reference values established by the guidelines of the Agency for Toxic Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA) (0.4 µg/L), whereas blood Pb levels (1.28 µg/dL-3.98 µg/dL) were below the ATSDR reference values (≤5 µg/dL), we believe that these alterations could be due especially to Cd, even if we cannot exclude a possible additional effect of Pb. Our results highlighted that oocytes were affected in maturation and quality, whereas CCs showed scarcely active steroidogenic elements. Regressing CCs, with cytoplasmic alterations, were also numerous. According to Cd's endocrine-disrupting activity, the poor steroidogenic activity of CCs might correlate with delayed oocyte cytoplasmic maturation. So, we conclude that levels of heavy metals in the blood and the FF might negatively affect fertilization, embryo development, and pregnancy, compromising oocyte competence in fertilization both directly and indirectly, impairing CC steroidogenic activity, and inducing CC apoptosis.
Collapse
Affiliation(s)
- Selenia Miglietta
- Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Sapienza University, 00165 Rome, Italy; (E.B.); (S.A.N.); (G.F.)
| | - Loredana Cristiano
- Department of Life Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy; (L.C.); (G.M.)
| | - Ezio Battaglione
- Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Sapienza University, 00165 Rome, Italy; (E.B.); (S.A.N.); (G.F.)
| | - Guido Macchiarelli
- Department of Life Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy; (L.C.); (G.M.)
| | - Stefania Annarita Nottola
- Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Sapienza University, 00165 Rome, Italy; (E.B.); (S.A.N.); (G.F.)
| | - Maria Paola De Marco
- Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Sant’Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy; (M.P.D.M.); (F.C.); (D.C.)
| | - Flavia Costanzi
- Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Sant’Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy; (M.P.D.M.); (F.C.); (D.C.)
| | - Mauro Schimberni
- GENERA Centers for Reproductive Medicine, Clinica Valle Giulia, 00197 Rome, Italy;
| | - Nicola Colacurci
- Department of Woman Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy;
| | - Donatella Caserta
- Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Sant’Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy; (M.P.D.M.); (F.C.); (D.C.)
| | - Giuseppe Familiari
- Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Sapienza University, 00165 Rome, Italy; (E.B.); (S.A.N.); (G.F.)
| |
Collapse
|
2
|
Makieva S, Scotti GM, Lazarevic D, Giacomini E, Ottolina J, Bartiromo L, Schimberni M, Alteri A, Pavone V, Minetto S, Papaleo E, Morelli M, Tonon G, Viganò P. P-240 Human extracellular vesicles (EVs) secreted by aneuploid embryos potentiate development of non-invasive PGT-A RNA biomarkers and stimulate MUC1 up-regulation in primary endometrial stromal cells (ESCs). Hum Reprod 2021. [DOI: 10.1093/humrep/deab127.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Could EVs secreted by aneuploid embryos a) serve for development of RNA biomarkers for PGT-A and b) elicit a relevant transcriptomic response in decidualised ESCs?
Summary answer
Aneuploid embryo EVs a) contain PPM1J, LINC00561, ANKRD34C and TMED10 in differential abundance from euploid EVs and b) induce up-regulation of MUC1 in decidualised ESCs.
What is known already
Embryo aneuploidy accounts for approximately 50% of all recurrent implantation failures in women >35 years old. PGT-A identifies euploid embryos to increase implantation probability but the technology is controversial as it requires an invasive embryo biopsy with an elusive long-term biosafety. The development of non-invasive methods to screen out aneuploid embryos is paramount. It is also critical to decode the embryo-endometrial dialog underlying implantation failure. We have previously reported that IVF embryos secrete EVs that can be internalised by ESCs, conceptualising that successful implantation to the endometrium is facilitated by EVs, which may additionally serve as biomarkers of ploidy status.
Study design, size, duration
Embryos destined for biopsy on days 5-7 for PGT-A were grown under standard conditions. Spent media (30μl) were collected from euploid (n = 175) and aneuploid embryos (n = 145) at both cleavage (days 1-3) and blastocyst (days 3-5) stage. Media samples from n = 35 cleavage embryos were pooled in order to obtain five euploid and four aneuploidy pools. Blastocyst media were pooled to create one euploid and one aneuploid pool. ESCs were obtained from five women undergoing diagnostic laparoscopy.
Participants/materials, setting, methods
The study was realised at a research hospital. EVs were isolated from euploid and aneuploid Day3 pools with differential ultracentrifugation and EV-RNA sequencing was performed following the SMARTer Stranded Total RNA-Seq approach. ESCs were decidualised (E2:10nM, P4:1uM, cAMP:0.5 mM twice every 48 hours) and treated for 24 hours with 50 ng/ml euploid or aneuploid EVs extracted from blastocyst media. RNA sequencing was performed on ESCs following the Truseq RNAseq protocol.
Main results and the role of chance
Aneuploid cleavage stage embryos (n = 4) secreted EVs that were less abundant in RNA fragments originating from the genes PPM1J (log2fc=-5.13, p = 0.011), LINC00561 (log2fc=-7.87, p = 0.010) and ANKRD34C (log2fc=-7.30, p = 0.017) and more abundant in TMED10 (log2fc=1.63 p = 0.025) compared to EVs (n = 5) from euploid embryos. Decidualisation per se induced downregulation of MUC1 (log2FC=-0.54, p = 0.0028) in ESCs as prerequisite for the establishment of receptive endometrium. The expression of MUC1 transcript in decidualised ESCs was significantly increased following treatment with aneuploid compared to euploid embryo-secreted EVs (log2FC=0.85, p = 0.0201).
Limitations, reasons for caution
The findings of the study may require validation utilising a second cohort of EVs samples.
Wider implications of the findings
This discovery that the RNA cargo of EVs secreted from aneuploid cleavage stage embryos is diverse from that of euploid embryos potentiates the development of non-invasive methodology for PGT-A. The upregulation of MUC1 in decidualised ESCs following aneuploid embryo EV treatment proposes a new mechanism underlying implantation failure.
Trial registration number
NA
Collapse
Affiliation(s)
- S Makieva
- IRCCS San Raffaele Scientific Institute, Reproductive Sciences Laboratory, Milan, Italy
| | - G M Scotti
- IRCCS San Raffaele Scientific Institute, Center for Omics Sciences, Milan, Italy
| | - D Lazarevic
- IRCCS San Raffaele Scientific Institute, Center for Omics Sciences, Milan, Italy
| | - E Giacomini
- IRCCS San Raffaele Scientific Institute, Reproductive Sciences Laboratory, Milan, Italy
| | - J Ottolina
- IRCCS San Raffaele Scientific Institute, Centro Scienze della Natalità, Milan, Italy
| | - L Bartiromo
- IRCCS San Raffaele Scientific Institute, Department of Obstetrics and Gynecology, Milan, Italy
| | - M Schimberni
- IRCCS San Raffaele Scientific Institute, Department of Obstetrics and Gynecology, Milan, Italy
| | - A Alteri
- IRCCS San Raffaele Scientific Institute, Centro Scienze della Natalità, Milan, Italy
| | - V Pavone
- IRCCS San Raffaele Scientific Institute, Reproductive Sciences Laboratory, Milan, Italy
| | - S Minetto
- IRCCS San Raffaele Scientific Institute, Centro Scienze della Natalità, Milan, Italy
| | - E Papaleo
- IRCCS San Raffaele Scientific Institute, Centro Scienze della Natalità, Milan, Italy
| | - M Morelli
- IRCCS San Raffaele Scientific Institute, Center for Omics Sciences, Milan, Italy
| | - G Tonon
- IRCCS San Raffaele Scientific Institute, Center for Omics Sciences, Milan, Italy
| | - P Viganò
- IRCCS San Raffaele Scientific Institute, Reproductive Sciences Laboratory, Milan, Italy
| |
Collapse
|
3
|
Makieva S, Scotti GM, Lazarevic D, Giacomini E, Ottolina J, Bartiromo L, Schimberni M, Alteri A, Pavone V, Minetto S, Papaleo E, Morelli M, Tonon G, Viganò P. P–240 Human extracellular vesicles (EVs) secreted by aneuploid embryos potentiate development of non-invasive PGT-A RNA biomarkers and stimulate MUC1 up-regulation in primary endometrial stromal cells (ESCs). Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
Could EVs secreted by aneuploid embryos a) serve for development of RNA biomarkers for PGT-A and b) elicit a relevant transcriptomic response in decidualised ESCs?
Summary answer
Aneuploid embryo EVs a) contain PPM1J, LINC00561, ANKRD34C and TMED10 in differential abundance from euploid EVs and b) induce up-regulation of MUC1 in decidualised ESCs.
What is known already
Embryo aneuploidy accounts for approximately 50% of all recurrent implantation failures in women >35 years old. PGT-A identifies euploid embryos to increase implantation probability but the technology is controversial as it requires an invasive embryo biopsy with an elusive long-term biosafety. The development of non-invasive methods to screen out aneuploid embryos is paramount. It is also critical to decode the embryo-endometrial dialog underlying implantation failure. We have previously reported that IVF embryos secrete EVs that can be internalised by ESCs, conceptualising that successful implantation to the endometrium is facilitated by EVs, which may additionally serve as biomarkers of ploidy status.
Study design, size, duration
Embryos destined for biopsy on days 5–7 for PGT-A were grown under standard conditions. Spent media (30μl) were collected from euploid (n = 175) and aneuploid embryos (n = 145) at both cleavage (days 1–3) and blastocyst (days 3–5) stage. Media samples from n = 35 cleavage embryos were pooled in order to obtain five euploid and four aneuploidy pools. Blastocyst media were pooled to create one euploid and one aneuploid pool. ESCs were obtained from five women undergoing diagnostic laparoscopy.
Participants/materials, setting, methods
The study was realised at a research hospital. EVs were isolated from euploid and aneuploid Day3 pools with differential ultracentrifugation and EV-RNA sequencing was performed following the SMARTer Stranded Total RNA-Seq approach. ESCs were decidualised (E2:10nM, P4:1uM, cAMP:0.5 mM twice every 48 hours) and treated for 24 hours with 50 ng/ml euploid or aneuploid EVs extracted from blastocyst media. RNA sequencing was performed on ESCs following the Truseq RNAseq protocol.
Main results and the role of chance
Aneuploid cleavage stage embryos (n = 4) secreted EVs that were less abundant in RNA fragments originating from the genes PPM1J (log2fc=–5.13, p = 0.011), LINC00561 (log2fc=–7.87, p = 0.010) and ANKRD34C (log2fc=–7.30, p = 0.017) and more abundant in TMED10 (log2fc=1.63 p = 0.025) compared to EVs (n = 5) from euploid embryos. Decidualisation per se induced downregulation of MUC1 (log2FC=–0.54, p = 0.0028) in ESCs as prerequisite for the establishment of receptive endometrium. The expression of MUC1 transcript in decidualised ESCs was significantly increased following treatment with aneuploid compared to euploid embryo-secreted EVs (log2FC=0.85, p = 0.0201).
Limitations, reasons for caution
The findings of the study may require validation utilising a second cohort of EVs samples.
Wider implications of the findings: This discovery that the RNA cargo of EVs secreted from aneuploid cleavage stage embryos is diverse from that of euploid embryos potentiates the development of non-invasive methodology for PGT-A. The upregulation of MUC1 in decidualised ESCs following aneuploid embryo EV treatment proposes a new mechanism underlying implantation failure.
Trial registration number
NA
Collapse
Affiliation(s)
- S Makieva
- IRCCS San Raffaele Scientific Institute, Reproductive Sciences Laboratory, Milan, Italy
| | - G M Scotti
- IRCCS San Raffaele Scientific Institute, Center for Omics Sciences, Milan, Italy
| | - D Lazarevic
- IRCCS San Raffaele Scientific Institute, Center for Omics Sciences, Milan, Italy
| | - E Giacomini
- IRCCS San Raffaele Scientific Institute, Reproductive Sciences Laboratory, Milan, Italy
| | - J Ottolina
- IRCCS San Raffaele Scientific Institute, Centro Scienze della Natalità, Milan, Italy
| | - L Bartiromo
- IRCCS San Raffaele Scientific Institute, Department of Obstetrics and Gynecology, Milan, Italy
| | - M Schimberni
- IRCCS San Raffaele Scientific Institute, Department of Obstetrics and Gynecology, Milan, Italy
| | - A Alteri
- IRCCS San Raffaele Scientific Institute, Centro Scienze della Natalità, Milan, Italy
| | - V Pavone
- IRCCS San Raffaele Scientific Institute, Reproductive Sciences Laboratory, Milan, Italy
| | - S Minetto
- IRCCS San Raffaele Scientific Institute, Centro Scienze della Natalità, Milan, Italy
| | - E Papaleo
- IRCCS San Raffaele Scientific Institute, Centro Scienze della Natalità, Milan, Italy
| | - M Morelli
- IRCCS San Raffaele Scientific Institute, Center for Omics Sciences, Milan, Italy
| | - G Tonon
- IRCCS San Raffaele Scientific Institute, Center for Omics Sciences, Milan, Italy
| | - P Viganò
- IRCCS San Raffaele Scientific Institute, Reproductive Sciences Laboratory, Milan, Italy
| |
Collapse
|
4
|
Vaiarelli A, Cimadomo D, Colamaria S, Giuliani M, Argento C, Fabozzi G, Ferrero S, Schimberni M, Holte J, Trabucco E, Livi C, Gennarelli G, Bongioanni F, Rienzi L, Ubaldi FM. P–606 A second stimulation in the same ovarian cycle rescues advanced-maternal-age patients obtaining ≤ 3 blastocysts after the conventional approach by preventing treatment-discontinuation. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Is double stimulation in the same ovarian cycle (DuoStim) a valuable strategy to rescue advanced-maternal-age patients obtaining ≤ 3 blastocysts for chromosomal-testing after conventional stimulation?
Summary answer
DuoStim is effective to prevent treatment discontinuation thereby increasing the 1-year cumulative-live-birth-rate among advanced-maternal-age patients obtaining 0–3 blastocysts after a first conventional stimulation.
What is known already
Folliculogenesis is characterized by continuous waves of follicular growth. DuoStim approach exploits these dynamics to conduct two stimulations in a single ovarian cycle and improve the prognosis of advanced-maternal-age and/or reduced-ovarian-reserve women. Independent groups worldwide successfully adopted DuoStim with various regimens reporting similar oocyte/embryo competence after both stimulations. Recently, we have demonstrated the fruitful adoption of DuoStim in patients fulfilling the Bologna criteria, especially because of the prevention of treatment discontinuation. Here we aimed at investigating whether DuoStim can be adopted to rescue poor prognosis patients obtaining 0–3 blastocysts after the conventional approach.
Study design, size, duration
Proof-of-concept matched case-control study. All patients obtaining 0–3 blastocysts after conventional-stimulation between 2015–2018 were proposed DuoStim. The 143 couples who accepted were matched for maternal age, sperm factor, cumulus-oocyte-complexes and blastocysts obtained after the first stimulation to 143 couples who did not. The primary outcome was the 1-year cumulative-live-birth-rate. If not delivering, the control group had 1 year to undergo a second attempt with conventional-stimulation. All treatments were concluded (live-birth achieved or no euploid left).
Participants/materials, setting, methods
Only GnRH-antagonist with recombinant-gonadotrophins and agonist trigger stimulation protocols were adopted. All cycles entailed ICSI with ejaculated sperm, blastocyst culture, trophectoderm biopsy, comprehensive-chromosome-testing and vitrified-warmed euploid single-embryo-transfer(s). Cumulative-live-birth-rate was calculated per patient considering both stimulations in the same ovarian cycle (DuoStim group) or up to two stimulations in 1 year (control group). Treatment discontinuation rate in the control group was calculated as patients who did not return for a second stimulation among non-pregnant ones.
Main results and the role of chance
Among the 286 couples included (41.0±2.9yr;4.9±3.1 cumulus-oocytes-complexes and 0.8±0.9 blastocysts), 126 (63 per group), 98 (49 per group), 52 (26 per group) and 10 (5 per group) obtained 0,1,2 and 3 blastocysts after the first stimulation, respectively. The cumulative-live-birth-rate was 9% in the control group after the first attempt (N = 13/143). Among the 130 non-pregnant patients, only 12 returned within 1-year (165±95days later;discontinuation rate=118/130,91%), and 3 delivered. Thus, the cumulative-live-birth-rate from two stimulations in 1-year was 11% (N = 16/143). In the DuoStim group, the cumulative-live-birth-rate was 24% (N = 35/143; Fisher’s-exact-test< 0.01,power=80%). The odds-ratio of delivering in the DuoStim versus the control group adjusted for all matching criteria was 3.3,95%CI:1.6–7.0,p<0.01. This difference (0%,22%,15% and 20% in the control versus 10%,31%,46% and 40% in the DuoStim group among patients obtaining 0,1,2 and 3 blastocysts at the first stimulation, respectively) is mainly due to treatment discontinuation in the control group (98%,65%,77% and 80% among patients obtaining 0,1,2 and 3 blastocysts at the first stimulation, respectively) and the further increased maternal age at the time of second retrieval (∼6 months). Notably, 2 patients delivered 2 live-births after DuoStim (none in the control) and 14 patients with a live-birth have euploid blastocysts left (2 in the control).
Limitations, reasons for caution
Randomized-controlled-trials and cost-effectiveness analyses are desirable to confirm these data. Moreover, 75% of the patients included were >39yr and 44% obtained no blastocyst after the first stimulation. Therefore future studies among younger women and/or more women obtaining ≥1 blastocyst are advisable to set reasonable cut-off values to apply this strategy.
Wider implications of the findings: A second stimulation in the same ovarian cycle might be envisioned as a rescue strategy for poor IVF outcomes after a first stimulation, so to prevent treatment discontinuation and increase the cumulative-live-birth-rate. This is feasible since 6–7 days span the first and the second stimulation in the DuoStim protocol.
Trial registration number
none
Collapse
Affiliation(s)
- A Vaiarelli
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - D Cimadomo
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - S Colamaria
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - M Giuliani
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - C Argento
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - G Fabozzi
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - S Ferrero
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | | | - J Holte
- Carl Von Linné Clinic, GeneraLife IVF, Uppsala, Sweden
| | - E Trabucco
- Clinica Ruesch, GeneraLife IVF, Naples, Italy
| | - C Livi
- Demetra, GeneraLife IVF, Florence, Italy
| | | | | | - L Rienzi
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - F M Ubaldi
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| |
Collapse
|
5
|
Vaiarelli A, Cimadomo D, Conforti A, Schimberni M, Giuliani M, D'Alessandro P, Colamaria S, Alviggi C, Rienzi L, Ubaldi FM. Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series. Fertil Steril 2019; 113:121-130. [PMID: 31837743 DOI: 10.1016/j.fertnstert.2019.09.012] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2019] [Revised: 09/04/2019] [Accepted: 09/09/2019] [Indexed: 10/25/2022]
Abstract
OBJECTIVE To assess the clinical contribution of luteal-phase stimulation (LPS) to follicular-phase stimulation (FPS) in a single ovarian cycle (DuoStim) for poor responder patients fulfilling the Bologna criteria. DESIGN Observational study (years 2015-2017) including women satisfying ≥2 of the following characteristics: maternal age ≥40 years and/or ≤3 oocytes retrieved after previous conventional stimulation and/or reduced ovarian reserve (i.e., antral follicle count <7 follicles or antimüllerian hormone <1.1 ng/mL). The LPS was started regardless of the outcome of the FPS. SETTING Private in vitro fertilization center. PATIENT(S) A total of 100 of 297 patients fulfilling the Bologna criteria chose to undergo DuoStim. INTERVENTION(S) The FPS and LPS with the same antagonist protocol and agonist trigger, intracytoplasmic sperm injection with ejaculated sperm, preimplantation genetic testing for aneuploidies, and vitrified-warmed euploid single blastocyst transfer. MAIN OUTCOME MEASURE(S) The contribution of LPS to the cumulative live birth rate (CLBR) per intention-to-treat (ITT). RESULT(S) Patients (100) underwent FPS (maternal age, 42.1 ± 1.4 y; previous in vitro fertilization cycles with ≤3 collected oocytes, 0.7 ± 0.9; antral follicle count, 3.8 ± 1.2 follicles; and antimüllerian hormone, 0.56 ± 0.3 ng/mL). Ninety-one patients completed DuoStim. All patients were included in the analysis. More oocytes were obtained after LPS with similar developmental and chromosomal competence as paired FPS-derived ones. The CLBR per ITT increased from 7% after FPS to 15% after DuoStim. Conversely, the CLBR per ITT among the 197 patients that chose a conventional controlled ovarian stimulation strategy was 8%, as only 17 patients who were not pregnant returned for a second stimulation after the first attempt (drop-out rate, 81%). CONCLUSION(S) The LPS-derived oocytes increased the CLBR per ITT in a single ovarian cycle in patients fulfilling the Bologna criteria. The DuoStim strategy is promising to manage this thorny population of patients, especially to avoid discontinuation after a first failed attempt.
Collapse
Affiliation(s)
- Alberto Vaiarelli
- Clinica Valle Giulia, G.EN.E.R.A., Centers for Reproductive Medicine, BioRoma, Rome, Rome, Italy.
| | - Danilo Cimadomo
- Clinica Valle Giulia, G.EN.E.R.A., Centers for Reproductive Medicine, BioRoma, Rome, Rome, Italy
| | - Alessandro Conforti
- Department of Neuroscience, Reproductive Science and Odontostomatology, University of Naples, Federico II, Naples, Italy
| | | | - Maddalena Giuliani
- Clinica Valle Giulia, G.EN.E.R.A., Centers for Reproductive Medicine, BioRoma, Rome, Rome, Italy
| | - Pietro D'Alessandro
- Clinica Ruesch, G.EN.E.R.A. Centers for Reproductive Medicine, Naples, Italy
| | - Silvia Colamaria
- Clinica Valle Giulia, G.EN.E.R.A., Centers for Reproductive Medicine, BioRoma, Rome, Rome, Italy
| | - Carlo Alviggi
- Department of Neuroscience, Reproductive Science and Odontostomatology, University of Naples, Federico II, Naples, Italy
| | - Laura Rienzi
- Clinica Valle Giulia, G.EN.E.R.A., Centers for Reproductive Medicine, BioRoma, Rome, Rome, Italy
| | - Filippo Maria Ubaldi
- Clinica Valle Giulia, G.EN.E.R.A., Centers for Reproductive Medicine, BioRoma, Rome, Rome, Italy
| |
Collapse
|
6
|
Abstract
Hundreds of thousands of young women are diagnosed with cancer each year, and due to recent advances in screening programs, diagnostic methods and treatment options, survival rates have significantly improved. Radiation therapy plays an important role in cancer treatment and in some cases it constitutes the first therapy proposed to the patient. However, ionizing radiations have a gonadotoxic action with long-term effects that include ovarian insufficiency, pubertal arrest and subsequent infertility. Cranial irradiation may lead to disruption of the hypothalamic-pituitary-gonadal axis, with consequent dysregulation of the normal hormonal secretion. The uterus might be damaged by radiotherapy, as well. In fact, exposure to radiation during childhood leads to altered uterine vascularization, decreased uterine volume and elasticity, myometrial fibrosis and necrosis, endometrial atrophy and insufficiency. As radiations have a relevant impact on reproductive potential, fertility preservation procedures should be carried out before and/or during anticancer treatments. Fertility preservation strategies have been employed for some years now and have recently been diversified thanks to advances in reproductive biology. Aim of this paper is to give an overview of the various effects of radiotherapy on female reproductive function and to describe the current fertility preservation options.
Collapse
Affiliation(s)
- Roberto Marci
- Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, via L. Borsari, 46, 44121, Ferrara, Italy.
- Faculty of Medicine, University of Geneva, Geneva, Switzerland.
- Division of Obstetrics and Gynecology, University Hospital of Geneva, Boulevard de la Cluse 30, 1205, Geneva, Switzerland.
| | - Maddalena Mallozzi
- Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, University of Rome "Sapienza", Rome, Italy
| | - Luisa Di Benedetto
- Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, University of Rome "Sapienza", Rome, Italy
| | - Mauro Schimberni
- Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, University of Rome "Sapienza", Rome, Italy
| | - Stefano Mossa
- Radiation Oncology Unit, S Andrea Hospital, University Sapienza, Rome, Italy
| | - Ilaria Soave
- Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, University of Rome "Sapienza", Rome, Italy
| | - Stefano Palomba
- Unit of Obstetrics and Gynecology, Grande Ospedale Metropolitano 'Bianchi - Melacrino - Morelli', Reggio Calabria, Italy
| | - Donatella Caserta
- Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, University of Rome "Sapienza", Rome, Italy
| |
Collapse
|
7
|
Nobili F, Lukic A, Puccica I, Vitali M, Schimberni M, Manzara F, Frega A, Mossa B, Moscarini† M, Caserta D. The relevance of fascial surgical repair in the management of pelvic organ prolapse (POP). CLIN EXP OBSTET GYN 2017. [DOI: 10.12891/ceog4001.2017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
8
|
Bordi G, D'Ambrosio A, Gallotta I, Di Benedetto L, Frega A, Torcia F, Schimberni M, Bonito M, Caserta D. The influence of ovulation induction and assisted conception on maternal and perinatal outcomes of twin pregnancies. Eur Rev Med Pharmacol Sci 2017; 21:3998-4006. [PMID: 29028104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
OBJECTIVE To compare obstetrical and neonatal outcomes of twin pregnancies conceived via assisted reproductive technology (ART) with those of naturally conceived ones and to investigate the influence of the ART procedure type on these parameters. PATIENTS AND METHODS This observational study included 450 ART and 647 spontaneous twin pregnancies delivered over 15 years at a single university-based hospital of Rome, Italy. Logistic and linear regression models adjusted for confounding factors were used to evaluate the effect of ART and the type of assisted conception (IVF/ICSI, ovulation induction ± intrauterine insemination, egg/embryo donation) on maternal and perinatal outcomes. RESULTS The mean gestational age was significantly lower in pregnancies conceived via ART. The occurrence rates of gestational diabetes, antenatal admission, prophylactic administration of corticosteroid, very preterm delivery and neonatal intensive care unit admission were higher in the ART group. Twin pregnancies achieved via egg/embryo donation had a lower risk of maternal thrombocytopenia and cervical incompetence and were at greater risk of receiving corticosteroid prophylaxis and patent ductus arteriosus than pregnancies obtained by IVF/ICSI. Conception by ovulation induction was associated with reduced risk of hyperemesis gravidarum and longer neonatal hospitalization compared to pregnancies obtained by IVF/ICSI. CONCLUSIONS Assisted conception was associated with adverse obstetrical outcomes and lower gestational age, but after adjustment for gestational age neonatal immediate outcomes were similar to those observed in the spontaneous group. There were no many important differences in the outcomes of twin pregnancies obtained by a different type of conception.
Collapse
Affiliation(s)
- G Bordi
- Department of Surgical and Medical Sciences and Translational Medicine, Sapienza University of Rome, S. Andrea Hospital, Rome, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Frega A, Verrone A, Manzara F, Schimberni M, Catalano A, Milazzo GN, Marziani R, Cozza G, Bianchi P, French D, Sesti F, Caserta D. Expression of E6/E7 HPV-DNA, HPV-mRNA and colposcopic features in management of CIN2/3 during pregnancy. Eur Rev Med Pharmacol Sci 2016; 20:4236-4242. [PMID: 27831652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
OBJECTIVE The incidence of abnormal cervical cytology in pregnancy is similar to that reported for non-pregnant women. Furthermore, 1% of pregnant women annually screened for cervical cancer will be diagnosed with cervical intraepithelial neoplasia (CIN) of various degrees. For this reason, Pap smear should be performed in the first trimester of pregnancy. The persistence of HR-HPV infection is related to the development of CIN. However, the relationship between CIN and HR-HPV infection during pregnancy and postpartum can hardly be found. The aim of this work was to assess the proper management of abnormal cytology during and after pregnancy evaluating regression rate, persistence rate and risk of progression and the predictive role of HPV molecular tests. PATIENTS AND METHODS Patients with abnormal cervical cytology were followed-up using colposcopy and colposcopy-directed biopsies every 12 weeks. Molecular tests were performed at the moment of the cytological diagnosis. Patients not treated in pregnancy were re-evaluated with cytology, colposcopy, biopsies, HPV-DNA test and HPV-mRNA test for a final diagnosis 8 weeks postpartum. Women with a persistent CIN 2-3 lesion at this follow-up check, underwent an excisional procedure by LEEP and then re-evaluated every 6 months for a year. RESULTS HPV-DNA test showed a sensitivity of 90.5% and a negative predictive value of 96.4%. Specificity and positive predictive values were 67.9% and 43.2%, respectively. For HPV-mRNA test, a sensitivity of 76.2% and a NPV of 93.9% were found; specificity and PPV were 98.7% and 94.1% respectively. CONCLUSIONS An observational management based on the use of molecular test and particularly HPV-mRNA test for its higher specificity, is a reasonable possibility in the follow-up of CIN2/3 lesions during pregnancy.
Collapse
Affiliation(s)
- A Frega
- Department of Surgical and Medical Science and Translational Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Schimberni M, Ciardo F, Schimberni M, Giallonardo A, De Pratti V, Sbracia M. Short gonadotropin-releasing hormone agonist versus flexible antagonist versus clomiphene citrate regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial. Eur Rev Med Pharmacol Sci 2016; 20:4354-4361. [PMID: 27831635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
OBJECTIVE Poor responders represent a frustrating condition for couples undergoing IVF and clinicians, and their treatment remains disputed. To assess the efficacy and the most suitable protocol, we conducted a randomized controlled trial comparing three different protocols of ovarian stimulation in poor responder women: clomiphene citrate (CC) plus a high dose of gonadotropins and GnRH antagonist, flexible GnRH antagonist protocol and a short GnRH agonist protocol. PATIENTS AND METHODS Between July 2014 and December 2015 we enrolled 250 poor responders in a previous IVF cycle at least 3 months before. We divided into three groups: group A, 68 women treated with clomiphene citrate and FSH plus antagonist; Group B, 71 patients treated with FSH plus antagonist; Group C, 75 patients treated with FSH plus GnRH agonist. RESULTS The GnRH agonist protocol showed a significantly higher pregnancy rate (29.3% vs. 5.9% vs. 14.1% respectively) than the clomiphene and the GnRH antagonist protocol, number of mature oocytes collected, estradiol levels and endometrial thickness. The cost of medications for each baby born was lower for the GnRH agonist protocol than for the others; the implantation rate was significantly lower in the clomiphene group (4.8%) than in the GnRH antagonist group (9.3%) and the GnRH agonist groups (19.2%). No significant differences emerged for total FSH administered, days of stimulation, numbers of oocytes retrieved and embryos transferred. CONCLUSIONS This study demonstrates that short GnRH agonist protocol should be the first choice in poor responders; instead, clomiphene citrate should be avoided due to its very low success rate and high costs.
Collapse
Affiliation(s)
- M Schimberni
- Bioroma, Centre for Reproductive Medicine, Clinica Valle Giulia, Rome, Italy.
| | | | | | | | | | | |
Collapse
|
11
|
Frega A, Manzara F, Schimberni M, Guarino A, Catalano A, Bianchi P, Marziani R, Cozza G, Milazzo GN, French D, Caserta D. Human papilloma virus infection and cervical cytomorphological changing among intrauterine contraception users. Eur Rev Med Pharmacol Sci 2016; 20:3528-3534. [PMID: 27649651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
OBJECTIVE The increased use of the intrauterine contraception (IUC) in female population and its probable relationship with cervical squamous intraepithelial lesions and cervical cancer make necessary clarify the possible interaction between the device and the pre-neoplastic lesions. PATIENTS AND METHODS Seven hundred and eighty-nine patients users of IUC and 1491 patients ever users of IUC were followed every 6 months for 3 years. Each clinical control included Papanicolau test, colposcopy, HPV-DNA test and HPV-mRNA test. Also, in patients IUC users we analyzed the type of device, years of use and average age. RESULTS Cytological sampling, histological examination, HPV-DNA test and HPV-mRNA test showed that there are not significantly differences between patients with or without IUC. CONCLUSIONS None difference arose regarding persistence and progression between patients IUC users and IUC no users, for this reason, intrauterine contraception does not seem to be a co-causal factor in the possible development of cervical cancer.
Collapse
Affiliation(s)
- A Frega
- Department of Medical and Surgical Science and Translational Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Pulcinelli FM, Schimberni M, Marci R, Bellati F, Caserta D. Laparoscopic versus laparotomic surgery for adnexal masses: role in elderly. World J Surg Oncol 2016; 14:105. [PMID: 27056684 PMCID: PMC4823905 DOI: 10.1186/s12957-016-0861-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2015] [Accepted: 03/24/2016] [Indexed: 09/27/2023] Open
Abstract
BACKGROUND The purpose of this study is to compare laparoscopy (LPS) and laparotomy (LPT), in terms of surgical outcomes, in elderly patients (>65 years) with adnexal masses. METHODS We retrospectively reviewed a series of women older than 65 who had a diagnosis of adnexal masses. Then, all patients were divided into two different groups according to the type of surgery: 27 who underwent LPS (LPS group) and 24 who underwent LPT (LPT group). We took into consideration: age, comorbidity, histological diagnosis, surgery approach, and surgical outcome. Then, we calculated the percentages of all of these data and then χ (2) test and t-Student test were used to calculate the p value, to compare the two surgical techniques. A p value lower than 0.05 was considered to be statistically significant. RESULTS At first, we evaluated the relation between the diagnosis and the surgery approach, and we obtained statistically significant results for serous cyst, adenocarcinoma serous/mucinous, and others, and the table highlights that some of the benign masses were mostly treated with LPS, while borderline and malignant masses were treated with LPT. Then, we evaluated the comorbidities of the patients, and we found that those cases had a significantly higher prevalence of cardiovascular disease and metabolic diseases. Finally, we compared the surgery outcome of LPS versus LPT surgeries for adnexal masses in elderly women, and there were statistically significant results for postoperative complications, number of patients who needed drainage, and number of days of hospitalization after surgery. CONCLUSIONS Our results demonstrated that the patients who underwent LPS, compared to the patients who underwent LPT, have better outcomes in terms of postoperative complications (7.4 % with LPS and 37 % with LPT), number of patients who needed drainage (11.1 % with LPS and 62.5 % with LPT), and number of days of hospitalization after surgery, in term of mean (5 for LPS and 10.9 in term of LPT).
Collapse
Affiliation(s)
- F M Pulcinelli
- Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035/1039-00189, Rome, Italy.
| | - M Schimberni
- Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035/1039-00189, Rome, Italy
| | - R Marci
- Department of Morphology, Surgery and Experimental Medicine, Sant'Anna University Hospital, Via Aldo Moro, 8-44124, Cona, Ferrara, Italy
| | - F Bellati
- Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035/1039-00189, Rome, Italy
| | - D Caserta
- Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035/1039-00189, Rome, Italy
| |
Collapse
|
13
|
Mossa B, Schimberni M, Di Benedetto L, Mossa S. Ovarian transposition in young women and fertility sparing. Eur Rev Med Pharmacol Sci 2015; 19:3418-3425. [PMID: 26439037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE Ovarian transposition is a highly effective surgical procedure used to preserve ovarian function in premenopausal patients with cancers requiring postoperative or primary pelvic radiotherapy. Pelvic irradiation determines severe damage of ovarian DNA and iatrogenic ovarian failure with premature menopause, necessity of long-term hormone replacement therapy and infertility. MATERIALS AND METHODS We conducted an extensive research of the literature in Medline between January 2000 and April 2015 using the key-words "ovarian transposition radiotherapy", "radiotherapy gonadal function", radiotherapy fertility sparing". The population included young women with normal ovarian function affected by cancers that required pelvic radiotherapy. We have examined 32 articles reporting on 1189 women undergoing ovarian transposition. Median age was 32.5 years, follow up was median 48 months. The procedure has been performed in patients less than 40 years of age. Surgery has been achieved by laparotomy or laparoscoy. We have analyzed effects of radiotherapy on ovarian function. RESULTS The proportion of women treated by ovarian transposition preserved ovarian function was 70%. About 86% of patients did not develop ovarian cysts and in 98-99% of cases did not occur any metastatic disease. CONCLUSIONS Ovarian transposition is associated with significant preservation of ovarian function and a low frequency of complications as cysts and metastasis. In 31% of cases the procedure can fail. Further studies are needed to evaluate the efficacy of ovarian transposition and the follow up. Ovarian transposition should be discussed at the time of cancer diagnosis in every premenopausal woman requiring pelvic radiotherapy.
Collapse
Affiliation(s)
- B Mossa
- Surgical and Medical Department of Translational Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, "Sapienza" University of Rome, Rome, Italy.
| | | | | | | |
Collapse
|
14
|
Zinna M, Gentile M, Torcia F, Bianchi P, Cozza G, Marziani R, Milazzo GN, Catalano A, Di Properzio M, Manzara F, Schimberni M, Caserta D, Frega A. Diagnostic accuracy of sonohysterography vs hysteroscopy in benign uterine endocavitary findings. Eur Rev Med Pharmacol Sci 2015; 19:365-371. [PMID: 25720704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE To compare diagnostic accuracy of sonohysterography vs hysteroscopy in patients with benign uterine endocavitary findings. PATIENTS AND METHODS This retrospective study evaluated 202 patients submitted to sonohysterography after transvaginal ultrasound examination suspicious for uterine endocavitary findings. Cytological sample was taken and analyzed from the fluid used to distend the uterine cavity. Of 202 patients enrolled for this study, 86 patients underwent gynaecological surgery, of whom 77 were treated with operative hysteroscopy and 9 with other gynaecological surgical techniques. Statistical analysis was performed to evaluate diagnostic agreement between sonohysterography vs hysteroscopy and cytology vs histology. RESULTS Diagnostic concordance between sonohysterography and hysteroscopy was significant (k value 0.87). The correlation between cytological and histological findings had a moderate level of concordance (k value 0.49). CONCLUSIONS Sonohysterography provides a diagnostic accuracy as well as hysteroscopy, therefore, it could be considered an alternative procedure in the diagnosis of benign uterine endocavitary findings.
Collapse
Affiliation(s)
- M Zinna
- Department of Gynecological, Obstetric and Urological Sciences, "Sapienza" University of Rome, Sant'Andrea Hospital, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Ricciardi E, Vecchione A, Marci R, Schimberni M, Frega A, Maniglio P, Caserta D, Moscarini M. Clinical factors and malignancy in endometrial polyps. Analysis of 1027 cases. Eur J Obstet Gynecol Reprod Biol 2014; 183:121-4. [PMID: 25461364 DOI: 10.1016/j.ejogrb.2014.10.021] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2014] [Revised: 07/28/2014] [Accepted: 10/22/2014] [Indexed: 11/30/2022]
Abstract
STUDY OBJECTIVE To assess the prevalence of polyps carrying a malignancy and match association between clinical factors and oncologic progression. STUDY DESIGN A retrospective study (Canadian Task Force classification II-3) at a university hospital in Rome, Italy. We retrospectively analyzed data from 1027 women consecutively treated for endometrial polyps at our center in the period 2002-2011. The association of malignancy with hormonal status, tamoxifen, hypertension, symptoms, diabetes mellitus, obesity, and hormonal replacement therapy in pre- and post-menopausal women was assessed. RESULTS Mean age was 45.8±10.8 years. Benign polyps accounted for 95.8% of the total, pre-malignant for 2.67%, malignant for 1.54%. Our data showed that post-menopausal and older women (>60y) with endometrial polyps have a higher risk of developing a related endometrial cancer (OR: 3.05, 95% CI [1.54, 6.19], p<0.001 and OR: 2.8, 95% CI [1.38, 5.56], p≤0.003. Also we observed that women with AUB in the post-menopausal period displayed a risk of malignancy (OR: 31.1, 95% CI [10.3,111], p value <0.001). CONCLUSION Special attention should be drawn to symptomatic post-menopausal patients that appear to be at higher risk of malignancy. Symptomatic pre-menopausal women and asymptomatic post-menopausal women with polyps may be a group with intermediate-risk. These patients should undergo an individualized management plan, balancing both risks and benefits of surgical intervention after discussion with the patient.
Collapse
Affiliation(s)
- Enzo Ricciardi
- Department of Obstetrics, Gynecology and Urology, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy; Department of Obstetrics and Gynecology, Universitätsklinikum Freiburg, Freiburg i.Br., Germany.
| | - Andrea Vecchione
- Department of Pathology, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy
| | - Roberto Marci
- Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, Italy
| | - Mauro Schimberni
- Department of Obstetrics, Gynecology and Urology, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy
| | - Antonio Frega
- Department of Obstetrics, Gynecology and Urology, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy
| | - Paolo Maniglio
- Department of Obstetrics, Gynecology and Urology, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy
| | - Donatella Caserta
- Department of Obstetrics, Gynecology and Urology, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy
| | - Massimo Moscarini
- Department of Obstetrics, Gynecology and Urology, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy
| |
Collapse
|
16
|
Gentile M, Bianchi P, Sesti F, Sopracordevole F, Biamonti A, Scirpa P, Schimberni M, Cozza G, Marziani R, Di Martino G, Catalano A, Milazzo GN, Zinna M, Caserta D, Frega A. Adjuvant topical treatment with imiquimod 5% after excisional surgery for VIN 2/3. Eur Rev Med Pharmacol Sci 2014; 18:2949-2952. [PMID: 25339491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE Vulvar intraepithelial neoplasia (VIN) is a premalignant lesion of the vulva. The incidence of VIN is increasing. The surgery is currently the gold standard therapy for VIN, but Imiquimod could be a completion to surgery. The aim of this study is to compare the overall complete response, the recurrence rate and the risk factors for recurrence among two groups of patients: women with high grade VIN underwent surgery and patients treated with surgery plus Imiquimod. PATIENTS AND METHODS 80 patients with histologically diagnosed VIN 2/3 were enrolled in this prospective study. Our patients were divided into two groups: 40 women underwent surgery (A) and 40 patients were treated with surgery plus Imiquimod (B). All women had a 5-year follow-up. Recurrence rate and complete response were evaluated. The following patients' characteristics were analyzed: smoke, multifocal disease, multicentric disease, degree of the lesion. RESULTS In the group A recurrence rate was 44.8%, in the group B it was 48.4%. In both groups the presence of multifocal lesions (p = 0.02) and VIN 3 (p = 0.006) before treatment was associated with a higher risk of recurrence. CONCLUSIONS This study found that surgery remains the principal approach for VIN with regard to relapse and complete response since the treatment with Imiquimod associated with surgery didn't show a lower recurrence rate. Although the surgical treatments remain the best therapeutic option for VIN with regard to recurrence and overall complete response, the combined therapy seems to be an interesting modality, but further studies are needed.
Collapse
Affiliation(s)
- M Gentile
- Department of Gynaecological, Obstetric and Urological Sciences, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Thornhill A, Dibouni ZA, Shah T, Wheat S, Teitelbaum M, Walker M, Bissonette F, Yuzpe AL, Leveille MC, Gysler M, Johnson M, Sprague A, Villena JG, Aparicio JL, Gimenez J, Ten J, Perez RB, Scholten I, Chambers GM, van Loendersloot L, van der Veen F, Repping S, Gianotten J, Hompes PGA, Ledger W, Mol BWJ, Dior UP, Laufer N, Granovsky-Grisaru S, Yagel S, Yaffe H, Gielchinsky Y, Nelen WLDM, Huppelschoten AG, Verkerk EW, Adang EMM, Kremer JAM, Davies M, Rumbold A, Marino J, Willson K, Moore V, Giles L, Shebl O, Ebner T, Tews G, Haas D, Oppelt P, Mayer RB, Sanges F, Maggiulli R, Albricci L, Romano S, Scarica C, Schimberni M, Giallonardo A, Vettraino G, Ubaldi F, Rienzi L, Figueira RCS, Braga DPAF, Setti AS, Iaconelli A, Borges E, Obrado EC, Barredo DR, Navarro LL, Rodriguez AV, Rague PNB, Lletget BC, Padro RT, Oron G, Sokal-Arnon T, Zeadna A, Son WY, Holzer H, Tulandi T, Nakamura Y, Hattori H, Sato Y, Kuchiki M, Sakamoto E, Doshida M, Toya M, Kyono K, Nakajo Y, Nakamura Y, Hirata K, Doshida M, Toya M, Kyono K, Xin ZM, Zhu H, Sun YP, Jin HX, Song WY, Rodriguez A, Poisot F, Rodriguez F, Coll O, Vassena R, Vernaeve V, Ye Y, Wang L, Wang N, Le F, Jin F, Zheng Y, Jin F, Lou Y, Le F, Pan PP, Wang N, Wang LY, Hu CX, Liu SY, Zheng YM, Li LJ, Liu XZ, Xu XR, Huang HF, Jin F, Lin SL, Li M, Lian Y, Chen LX, Liu P, Kawwass JF, Crawford S, Kissin DM, Session DR, Boulet S, Jamieson DJ. Quality and safety of ART therapies. Hum Reprod 2013. [DOI: 10.1093/humrep/det219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Frega A, Sesti F, De Sanctis L, Pacchiarotti A, Votano S, Biamonti A, Sopracordevole F, Scirpa P, Catalano A, Caserta D, Gentile M, Schimberni M, Moscarini M. Pregnancy outcome after loop electrosurgical excision procedure for cervical intraepithelial neoplasia. Int J Gynaecol Obstet 2013; 122:145-9. [PMID: 23706863 DOI: 10.1016/j.ijgo.2013.03.013] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2012] [Revised: 03/04/2013] [Accepted: 04/19/2013] [Indexed: 11/15/2022]
Abstract
OBJECTIVE To determine pregnancy outcomes among women who underwent loop electrosurgical excision procedure (LEEP). METHODS In a case-control study in Italy, 475 pregnant women who underwent LEEP and 441 untreated pregnant women were enrolled between January 2003 and January 2007. Outcome measures were spontaneous abortion, preterm delivery, and at-term delivery rates. Continuous and discrete variables were analyzed via t, χ(2), and Fisher exact tests. Groups were compared by analysis of variance and Tukey HSD test. RESULTS The spontaneous abortion rate was 14.5% and 14.1% in the LEEP and untreated groups, respectively. The preterm delivery rate was 6.4% and 5.0% in the LEEP and untreated groups, respectively. The number of women with a cervical length of less than 30mm was higher in the LEEP group, but this did not influence preterm delivery rate (odds ratio [OR], 1.01; 95% confidence interval [CI], 0.53-1.95). Among women with a cervical length of less than 15mm, those treated with a wider removal of cervical tissue showed increased risk of preterm delivery (OR, 5.31; 95% CI, 1.01-28.07). CONCLUSION The preterm delivery rate was not higher among women who underwent LEEP than among untreated women. Preterm delivery was associated with cone size and cervical length in the second trimester.
Collapse
Affiliation(s)
- Antonio Frega
- Department of Gynecological, Obstetric and Urological Sciences, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Ricciardi E, Jakimovska M, Maniglio P, Schimberni M, Frega A, Kobal B, Moscarini M. Laparoscopic injury of the obturator nerve during fertility-sparing procedure for cervical cancer. World J Surg Oncol 2012; 10:177. [PMID: 22931409 PMCID: PMC3499187 DOI: 10.1186/1477-7819-10-177] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2012] [Accepted: 08/15/2012] [Indexed: 12/04/2022] Open
Abstract
Background Intraoperative injury of the obturator nerve has rarely been reported in patients with gynecological malignancies undergoing extensive radical surgeries. Irreversible damage of this nerve causes thigh paresthesia and claudication. Intraoperative repair may be done by end-to-end anastomosis or grafting when achieving tension-free anastomosis is not possible. Case presentation A 28-year-old woman with stage IB cervical cancer underwent fertility–sparing surgery, including conization and bilateral pelvic lymphadenectomy. The left obturator nerve was damaged intraoperatively during pelvic dissection. Conclusion Immediate laparoscopic repair was successful and there was no functional deficit in the left thigh for six months postoperatively.
Collapse
Affiliation(s)
- Enzo Ricciardi
- Department of Obstetrics and Gynecology, Sapienza University of Rome, Sant'Andrea Hospital, via di Grottarossa, 1035-1039, Rome 00189, Italy.
| | | | | | | | | | | | | |
Collapse
|
20
|
Ricciardi E, Di Martino G, Maniglio P, Schimberni M, Frega A, Jakimovska M, Kobal B, Moscarini M. Life-threatening bleeding after pelvic lymphadenectomy for cervical cancer: endovascular management of ruptured false aneurysm of the external iliac artery. World J Surg Oncol 2012; 10:149. [PMID: 22799878 PMCID: PMC3468405 DOI: 10.1186/1477-7819-10-149] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2012] [Accepted: 07/16/2012] [Indexed: 11/18/2022] Open
Abstract
Late rupture of external iliac artery pseudo-aneurysm is an uncommon complication in patients who undergo extensive gynecologic radical surgeries. A 28-year-old woman with stage IB cervical cancer underwent pelvic lymphadenectomy and extrafascial trachelectomy. Two months after surgery, massive bleeding from ruptured pseudo-aneurysm of the external iliac artery occurred. Endovascular management with covered stent placement was feasible and safe to stop bleeding.
Collapse
Affiliation(s)
- Enzo Ricciardi
- Department of Obstetrics and Gynecology, Sapienza University of Rome, Sant'Andrea Hospital, Roma, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Schimberni M, Ubaldi F, Giallonardo A, Rienzi L, Morgia F, Sbracia M. A controlled trial between natural cycle versus minimal stimulation in poor responder women: minimal stimulation works better in patients less than 40 years old. Fertil Steril 2011. [DOI: 10.1016/j.fertnstert.2011.07.1003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
22
|
Ricciardi E, Maniglio P, Schimberni M, Moscarini M. A case of high-grade leiomyosarcoma of the bladder with delayed onset and very poor prognosis. World J Surg Oncol 2010; 8:16. [PMID: 20302611 PMCID: PMC2847558 DOI: 10.1186/1477-7819-8-16] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2009] [Accepted: 03/19/2010] [Indexed: 02/02/2023] Open
Abstract
Mesenchymal tumors represent a small number of bladder cancer cases. Leiomyosarcoma is the most common histology with over 100 cases reported in the whole literature. This tumor is been historically considered as highly aggressive and showing a poor prognosis. Despite very low survival rates showed in older reports, some authors indicate that some patients could have a better outcome. We report a review of the literature and a case of high-grade LMS of the bladder in a 68 years old woman. Diagnosis was delayed and disease was locally advanced. Symptoms and imaging of our case first oriented to a gynecologic condition with an adnexal or uterine origin of the mass, and, a genitourinary origin could be unveiled only intra-operatively.
Collapse
Affiliation(s)
- Enzo Ricciardi
- Department of Gynecology, Perinatology and Child Health, Sapienza University of Rome, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00195 Rome, Italy.
| | | | | | | |
Collapse
|
23
|
Sbracia M, Colabianchi J, Giallonardo A, Giannini P, Piscitelli C, Morgia F, Montigiani M, Schimberni M. Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40. Fertil Steril 2009; 91:1842-7. [DOI: 10.1016/j.fertnstert.2008.02.165] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2007] [Revised: 02/26/2008] [Accepted: 02/26/2008] [Indexed: 11/25/2022]
|
24
|
Schimberni M, Morgia F, Colabianchi J, Giallonardo A, Piscitelli C, Giannini P, Montigiani M, Sbracia M. Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles. Fertil Steril 2008; 92:1297-1301. [PMID: 18793777 DOI: 10.1016/j.fertnstert.2008.07.1765] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2008] [Revised: 07/16/2008] [Accepted: 07/25/2008] [Indexed: 10/21/2022]
Abstract
OBJECTIVE To determine the role of the natural cycle for in vitro fertilization (IVF) in poor responder patients. DESIGN Retrospective survey. SETTING Private center for assisted reproduction. PATIENT(S) 294 women who were poor responders in a previous IVF cycle. INTERVENTION(S) Analysis of 500 consecutive natural cycles IVF. MAIN OUTCOME MEASURE(S) Number of cycles with oocytes, pregnancy rate per cycle, per transfer, and implantation rate. RESULT(S) Oocytes were found in 391 cases (78.1%), and cleaving embryos suitable for transfer were obtained in 285 cycles (57.0%). Pregnancy was observed in 49 cases, with a pregnancy rate of 9.8% per cycle, 17.1% per transfer, and 16.7% per patient. The patients were subdivided arbitrarily by the women's age into three groups. Patients 35 years old or younger showed a pregnancy rate of 18.1% per cycle, 29.2% per transfer, and 31.7% per patient. Women aged between 36 and 39 years showed a pregnancy rate of 11.7% per cycle, 20.6% per transfer, and 20.3% per patient. Women 40 years old or older showed a pregnancy rate of 5.8% per cycle, 10.5% per transfer, and 9.7% per patient. No differences were found for any of the evaluated parameters, independent of which cycle was the first, the second, third, fourth, or fifth, or further consecutive cycle. CONCLUSION(S) In poor responder patients, natural-cycle IVF is an effective treatment, especially in younger women.
Collapse
Affiliation(s)
- Mauro Schimberni
- Bioroma Centro di Riproduzione Assistita Casa di Cura "Paideia", Rome, Italy
| | - Francesco Morgia
- Bioroma Centro di Riproduzione Assistita Casa di Cura "Paideia", Rome, Italy
| | - Julio Colabianchi
- Bioroma Centro di Riproduzione Assistita Casa di Cura "Paideia", Rome, Italy
| | | | - Claudio Piscitelli
- Bioroma Centro di Riproduzione Assistita Casa di Cura "Paideia", Rome, Italy
| | - Pierluigi Giannini
- Bioroma Centro di Riproduzione Assistita Casa di Cura "Paideia", Rome, Italy
| | - Monica Montigiani
- Bioroma Centro di Riproduzione Assistita Casa di Cura "Paideia", Rome, Italy
| | - Marco Sbracia
- Center for Endocrinology and Reproductive Medicine (CERM), Rome, Italy.
| |
Collapse
|
25
|
Triolo L, Binazzi A, Cagnetti P, Carconi P, Correnti A, De Luca E, Di Bonito R, Grandoni G, Mastrantonio M, Rosa S, Schimberni M, Uccelli R, Zappa G. Air pollution impact assessment on agroecosystem and human health characterisation in the area surrounding the industrial settlement of Milazzo (Italy): a multidisciplinary approach. Environ Monit Assess 2008; 140:191-209. [PMID: 17671848 DOI: 10.1007/s10661-007-9859-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/28/2006] [Accepted: 07/03/2007] [Indexed: 05/16/2023]
Abstract
In order to evaluate the impact of atmospheric pollutants emitted by the industrial settlement of Milazzo (Italy) on agriculture, sulphur dioxide and ozone levels in air were monitored and the data were used to estimate yield losses of the most widespread cultures. Trace element concentrations in crops and soils were also detected and metabolic profiles of soil microbial communities were considered. Vibrio fischeri test was used to appraise airborne pollutant ecotoxicity and epidemiological studies on causes of death distribution were carried out to characterize health state of people living in the area. All the sampling points were selected in farms on the basis of a theoretical meteo-diffusive model of industrial air pollutants. Experimental SO2 and O3 values mainly exceeded the threshold established by Italian and EU regulations to protect vegetation and they correspond to estimated significant crop losses. Conversely toxic element residues in soils and in agroalimentary products were generally lower than the fixed values. SO2 and O3 concentrations, toxic element contents and ecotoxicity levels of airborne pollutants were not related only to industrial site emissions, while the fluctuations on metabolic profiles of soil microbial communities seem to agree with the predicted deposition of xenobiotic compounds from the industrial plants. The epidemiological study evidenced a better health state of populations living in the investigated area than in the Messina province and the Sicily region but, inside the area, males living in the municipalities closest to the industrial settlement exhibited a worst health state than those in the very far ones.
Collapse
Affiliation(s)
- L Triolo
- Department of Biotechnologies, Agro-industry and Health Protection, ENEA (Italian National Agency for New Technologies, Energy and the Environment) Casaccia Research Centre, Via Anguillarese 301, 00123 S. Maria di Galeria, Rome, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Caserta D, Marci R, Tatone C, Schimberni M, Vaquero E, Lazzarin N, Fazi A, Moscarini M. IVF pregnancies: Neonatal outcomes after the new Italian law on assisted reproduction technology (law 40/2004). Acta Obstet Gynecol Scand 2008; 87:935-9. [DOI: 10.1080/00016340802283681] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
27
|
Morgia F, Torti M, Montigiani M, Piscitelli C, Giallonardo A, Schimberni M, Giannini P, Sbracia M. Reply of the Authors. Fertil Steril 2006. [DOI: 10.1016/j.fertnstert.2006.08.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
28
|
Morgia F, Torti M, Montigiani M, Piscitelli C, Giallonardo A, Schimberni M, Giannini P, Sbracia M. Use of a medium buffered with N-hydroxyethylpiperazine-N-ethanesulfonate (HEPES) in intracytoplasmic sperm injection procedures is detrimental to the outcome of in vitro fertilization. Fertil Steril 2006; 85:1415-9. [PMID: 16600227 DOI: 10.1016/j.fertnstert.2005.10.050] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2005] [Revised: 10/25/2005] [Accepted: 10/25/2005] [Indexed: 11/25/2022]
Abstract
OBJECTIVE This study was conducted to determine whether N-hydroxyethylpiperazine-N-ethanesulfonate (HEPES)-buffered medium used for the microinjection of sperm into oocytes may be detrimental for the embryo. DESIGN Controlled randomized study. SETTING Private IVF center. PATIENT(S) Women (n = 708) undergoing ICSI. INTERVENTION(S) The women were randomized into two study groups: 2,204 oocytes from 357 women were treated using a medium buffered with bicarbonate without HEPES during the ICSI procedure, and 2,168 oocytes from 351 women were treated using a medium buffered with HEPES during the ICSI procedure. MAIN OUTCOME MEASURE(S) Fertilization rate, degeneration rate, triploid rate, cleavage rate, embryo quality, pregnancy rate, implantation rate, and abortion rate. RESULT(S) Oocytes treated with a HEPES-buffered medium showed a statistically significant higher rate of triploid and degenerated oocytes after fertilization with ICSI compared with oocytes treated with a medium without HEPES. The embryos obtained from oocytes microinjected with a HEPES-buffered medium showed a statistically significant higher rate of highly fragmented embryos compared with the controls. Pregnancy rate and implantation rate were statistically significantly lower in the patient group with oocytes treated with the HEPES-buffered medium. The other parameters evaluated did not show any statistically significant differences. CONCLUSION(S) Our study showed that the use of media buffered with HEPES, during the microinjection of sperm into the oocytes, is detrimental for IVF outcome and should be avoided.
Collapse
Affiliation(s)
- Francesco Morgia
- Bioroma, Center of Assisted Reproduction, Paideia Hospital, Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Sbracia M, Farina A, Poverini R, Morgia F, Schimberni M, Aragona C. Short versus long gonadotropin-releasing hormone analogue suppression protocols for superovulation in patients ≥40 years old undergoing intracytoplasmic sperm injection. Fertil Steril 2005; 84:644-8. [PMID: 16169397 DOI: 10.1016/j.fertnstert.2005.02.046] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2004] [Revised: 02/22/2005] [Accepted: 02/22/2005] [Indexed: 10/25/2022]
Abstract
OBJECTIVE To determine whether the short or long protocol for controlled ovarian hyperstimulation works better in older patients undergoing IVF. DESIGN Controlled, randomized study. SETTING A single private IVF center. PATIENT(S) Two hundred twenty infertile women aged > or = 40 years undergoing IVF. INTERVENTION(S) At their first IVF cycle, the women were randomized into two study groups according to a computer-generated number sequence: 110 patients were treated with a long protocol, and the other 110 were treated with a short protocol for controlled ovarian hyperstimulation. MAIN OUTCOME MEASURE(S) Days of stimulation, E2 level at the day of hCG administration, amount of FSH administered, number of oocytes collected, number of embryos obtained, pregnancy rate, implantation rate. RESULT(S) Patients treated with a long protocol showed a significantly higher number of oocytes retrieved, a higher number of embryos obtained, and a higher pregnancy rate, both for cycle and transfer, compared with the short-protocol patients. The other parameters evaluated did not show any statistically significant differences. CONCLUSION(S) Our study showed that the long protocol performed better than the short protocol in older women. Our findings demonstrated that flare-up in older women might be detrimental.
Collapse
Affiliation(s)
- Marco Sbracia
- Center of Endocrinology and Reproductive Medicine, Rome, Italy.
| | | | | | | | | | | |
Collapse
|
30
|
Giannini P, Piscitelli C, Giallonardo A, Sbracia M, Morgia F, Torti M, Montigiani M, Schimberni M. Number of embryos transferred and implantation. Ann N Y Acad Sci 2005; 1034:278-83. [PMID: 15731319 DOI: 10.1196/annals.1335.029] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Multiple pregnancies are considered the most frequent and serious complication of assisted reproduction technology. To reduce the frequency of multiple pregnancies, several centers have adopted a policy of reducing the number of embryos transferred in the uterus, suggesting single embryo transfer. Even though a significant number of papers have been published on this issue, no general consensus exists on how many embryos to replace in the uterus and at which cleavage stage. We conducted a retrospective study on cycles performed throughout 2003, analyzing the relation between the number of embryos transferred and the pregnancy and implantation rates, evaluating also the role of the woman's age. No differences were found among the groups except in one-embryo transferred women, which were mostly natural cycles, for estradiol levels, number of mature oocytes retrieved, number of top quality embryos, and pregnancy rate. The implantation rate was significantly higher in the two-embryo transfers versus three-embryo transfers. We found higher pregnancy and implantation rates with similar multiple pregnancy rates in patients where only two embryos were transferred versus three embryos transfer when women were less than 35 years old. In women aged less than 35 years, which in turn have the higher expectancy of successful pregnancy and also the higher risk of multiple pregnancy, the single embryo transfer is a suitable choice for these patients.
Collapse
Affiliation(s)
- Pierluigi Giannini
- Bioroma Centro di Riproduzione Assistita Casa di Cura "Paideia," Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|
31
|
Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, Aragona C. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril 2004; 81:1542-7. [PMID: 15193474 DOI: 10.1016/j.fertnstert.2003.11.031] [Citation(s) in RCA: 94] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2002] [Revised: 11/11/2003] [Accepted: 11/11/2003] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To determine the efficacy of natural-cycle IVF compared with controlled ovarian hyperstimulation in poor responders. DESIGN Randomized, controlled study. SETTING Private center for assisted reproduction. PATIENT(S) One hundred twenty-nine women who were poor responders in a previous IVF cycle. INTERVENTION(S) Fifty-nine women underwent 114 attempts of natural-cycle IVF, and 70 women underwent 101 attempts of IVF with controlled ovarian hyperstimulation with microdose GnRH analog flare. MAIN OUTCOME MEASURE(S) Number of oocytes retrieved, pregnancy rate (PR) per cycle, PR per transfer, and implantation rate. RESULT(S) The poor responders treated with natural-cycle IVF and those treated with micro-GnRH analog flare showed similar PRs per cycle and per transfer. The women treated with natural-cycle IVF showed a statistically significant higher implantation rate (14.9%) compared with controls (5.5%). When subdivided into three groups according to age (<or=35 years, >or=36-39 years, >or=40 years), younger patients had a better PR than the other two groups. CONCLUSION(S) In poor responders, natural-cycle IVF is at least as effective as controlled ovarian hyperstimulation, especially in younger patients, with a better implantation rate.
Collapse
Affiliation(s)
- Francesco Morgia
- Bioroma Centro di Riproduzione Assistita Casa di Cura "Paideia, Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
32
|
Petti N, Anghel G, Schimberni M, De Rosa L, Mancini S, Metro G, Villaccio B, Majolino I. Successful paternity with microassisted fertilization after total body irradiation-based conditioning for autologous bone marrow transplantation. Hematol J 2004; 4:285-8. [PMID: 12872154 DOI: 10.1038/sj.thj.6200261] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
We present the case of a 20-year-old man with acute lymphoblastic leukemia who received chemotherapy with vincristine, adriamycin, cyclophosphamide, methotrexate, teniposide (VM-26), and bleomicin, followed by an autologous bone marrow transplantation after total body irradiation (TBI)-cyclophosphamide-based conditioning regimen. At 14 years, despite the severe oligoasthenospermia, he fathered a healthy child by assisted reproductive technique (ART) consisting in controlled ovarian hyperstimulation of the patient's wife, transvaginal ovum pick up and microinjection of the ovum with a previously isolated sperm cell from the patient (intracytoplasmatic sperm injection, ICSI). As far as we know, that is the first documented case of successful paternity using microassisted fertilization with ICSI technique in a patient submitted to TBI-based bone marrow transplantation.
Collapse
Affiliation(s)
- Nicola Petti
- Hematology and Bone Marrow Transplantation Unit, San Camillo-Forlanini Hospital, Rome, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Aragona C, Sbracia M, Morgia F, Schimberni M, Piscitelli C, Giannini P. IVF in poor responder patients: a controlled trial between natural cycle and micro-dose GnRH analogue flare. Fertil Steril 2003. [DOI: 10.1016/s0015-0282(03)01410-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
34
|
Marinoni E, Di Iorio R, Villaccio B, Letizia C, Aragona C, Schimberni M, Cosmi EV. Follicular fluid adrenomedullin concentrations in spontaneous and stimulated cycles: relationship to ovarian function and endothelin-1 and nitric oxide. Regul Pept 2002; 107:125-8. [PMID: 12137974 DOI: 10.1016/s0167-0115(02)00093-9] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The objective of this study was to determine concentration of adrenomedullin (AM) in follicular fluid and whether a correlation exists between AM and nitric oxide (NO) or endothelin-1 (ET-1) levels in follicular fluid, serum 17beta-estradiol or other parameters of ovarian function in spontaneous and gonadotrophin stimulated ovarian cycles. Follicular fluid samples were obtained at oocyte retrieval from 50 women who underwent an in vitro fertilization (IVF) program: 40 undergoing ovarian hyperstimulation with recombinant FSH and 10 had spontaneous ovarian cycles. AM, ET-1, and NO were detected in all of the follicular fluid samples and their concentrations were similar in spontaneous and stimulated cycles. In patients undergoing ovarian stimulation, follicular fluid AM levels correlated with serum 17beta-estradiol concentration. No correlation was found between follicular AM concentration and parameters of ovarian function. Similarly, no relationship was observed between ET-1, NO, and AM follicular fluid concentrations in either spontaneous or stimulated cycles. This study suggests a possible regulatory effect of the sexual hormones on AM production by the ovary during the ovulatory process. The site of AM secretion and its function (if any), however, remain to be established.
Collapse
Affiliation(s)
- Emanuela Marinoni
- Laboratory of Perinatal Medicine and Molecular Biology, 2nd Institute of Obstetrics and Gynecology, University La Sapienza, Viale Regina Elena, 324 I-00161, Rome, Italy.
| | | | | | | | | | | | | |
Collapse
|
35
|
Iacobelli M, Rienzi L, Morgia F, Ubaldi F, Schimberni M, Aragona C, Greco E, Nagy Z. R-127. Poor-quality day 3 embryos can have the potential to develop into viable blastocyst and provide pregnancy after freezing-thawing. Hum Reprod 1999. [DOI: 10.1093/humrep/14.suppl_3.335-b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
36
|
Ubaldi F, Nagy P, Rienzi L, Anniballo R, Morgia F, Iacobelli M, Ferrero S, Schimberni M, Aragona C, Greco E. P-249. Cessation of gonadotrophin releasing hormone agonist therapy and high dose of menotrophins for ovarian stimulation in low responders. Hum Reprod 1999. [DOI: 10.1093/humrep/14.suppl_3.265-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
37
|
Anniballo R, Nagy P, Rienzi L, Morgia F, Iacobelli M, Ferrero S, Schimberni M, Aragona C, Greco E, Ubaldi F. P-030. Predictive value of recovering spermatozoa in frozen-thawed preliminary testicular biopsies in non-obstructed azoospermic patients. Hum Reprod 1999. [DOI: 10.1093/humrep/14.suppl_3.154-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Montanino G, Marcoccia S, Montanino Oliva M, Schimberni M. [A rare case of ectopic pregnancy. Primary ovarian pregnancy]. Minerva Ginecol 1990; 42:321-4. [PMID: 2293077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
A rare case of primary ovarian pregnancy is reported. The multiple diagnostic problems and the unclear symptomatology delayed the time of the definitive diagnosis more than seventy five days. All the histological criteria for the classification of an ovarian pregnancy are faced in this case. The finding of a well conserved gestational sac and embryo inside the ovarian tissue makes this case even more rare and interesting. When there is a suspicion of ectopic or ovarian pregnancy the Authors strongly suggest an early laparoscopy to make a reliable and precocious diagnosis, avoid the risk of the hemoperitoneum, perform a conservative therapy and preserve the ovarian function with the patient's reproductive potential.
Collapse
Affiliation(s)
- G Montanino
- II Istituto di Clinica Ostetrica e Ginecologica dell'Università degli Studi di Roma La Sapienza
| | | | | | | |
Collapse
|
39
|
Franco JG, Schimberni M, Rojas FJ, Moretti-Rojas I, Stone SC. Reproducibility of the indirect immunobead assay for detecting sperm antibodies in serum. J Reprod Med 1989; 34:259-63. [PMID: 2715984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Although an immunobead assay (IBA) for the detection of antisperm antibodies was developed several years ago and has been used for the study of immunologic infertility, no data regarding its variability and reproducibility are yet available. We evaluated the intraassay reproducibility of the indirect IBA by testing aliquots of antisperm-antibody-positive sera from two patients against the same donor sperm sample. The interassay reproducibility was evaluated by testing a positive serum sample first with different sperm samples from the same donor and second with sperm samples from different donors. The results of those experiments showed that the indirect IBA has very low intraassay variation and greater interassay variability.
Collapse
Affiliation(s)
- J G Franco
- Department of Obstetrics and Gynecology, University of California-Irvine, Orange
| | | | | | | | | |
Collapse
|
40
|
Stone SC, Schimberni M, Schuster PA, Werlin LB, Weathersbee P. Incidence of multiple gestations in the presence of two or more mature follicles in the conception cycle. Fertil Steril 1987; 48:503-4. [PMID: 3114013 DOI: 10.1016/s0015-0282(16)59429-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
41
|
Maruotti G, Schimberni M, Timpano F, Vetrano G, Cetta L, Musenga M, Giallonardo A, Caridà S, Micara G, Aragona C. [Echo-guided extraction of oocytes by perurethral-transvesical route in a program for in vitro fertilization and embryo transfer]. Ann Ostet Ginecol Med Perinat 1987; 108:256-63. [PMID: 3442396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
42
|
Franco JG, Schimberni M, Stone SC. An immunobead assay for antibodies to spermatozoa in serum. Comparison with traditional agglutination and immobilization tests. J Reprod Med 1987; 32:188-90. [PMID: 3572899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Circulating sperm antibodies have been traditionally quantified by measuring sperm agglutination (SAT) and immobilization (SIT) in serum. Recently an indirect immunobead assay (IBA) for detecting these antibodies in serum has been reported. Immunobeads coated with rabbit antibody to one of the three major immunoglobulins (IgG, IgM and IgA) are used. The procedure involves mixing a Hepes washed sample of normal donor sperm with the individual sera followed by centrifugation and incubation with each type of immunobead preparation and observed for evidence of binding. Sera from 40 patients previously tested with SAT and SIT were compared in four groups. There was a good correlation between IgG-IBA and SIT and a poor correlation between IgG-IBA and SAT. The class of immunoglobulin detected most frequently was IgG.
Collapse
|
43
|
Falsetti L, Roggia A, Loda G, Turla R, Scagliola T, Schimberni M, Pontiroli AE. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia. Horm Metab Res 1983; 15:380-4. [PMID: 6618428 DOI: 10.1055/s-2007-1018730] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
59 patients affected by amenorrhea or anovulation, 37 of whom also with galactorrhea, and with hyperprolactinemia of unknown origin (idiopathic hyperprolactinemia, 24 patients) or due to a pituitary microadenoma (tumoral hyperprolactinemia, 35 patients) were treated with metergoline (4-12 mg/day) or with bromocriptine (2.5 to 10 mg/day) for 90 days. The effectiveness of the two treatments was assessed on clinical grounds and by evaluating at monthly intervals serum progesterone levels, during the presumed luteal phase, and serum prolactin levels. The success rate with the two drugs was superimposable in terms of disappearance of galactorrhea and return of menses, normalization of prolactin levels and induction of ovulation. Also the number of pregnancies obtained (7 with metergoline, 9 with bromocriptine) was similar. With both drugs, the majority of patients responded to the treatment within the first month.
Collapse
|
44
|
Falsetti L, Voltolini AM, Schimberni M, Pontiroli AE. Treatment of hyperprolactinaemia with metergoline for periods up to 5 years: clinical and biological tolerability. Curr Med Res Opin 1983; 8:327-32. [PMID: 6839798 DOI: 10.1185/03007998309112392] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Forty patients with hyperprolactinaemia were treated with metergoline (8 to 12 mg/day) for periods up to 5 years. Analysis of the results of clinical and biological tolerability showed that treatment was generally well tolerated and although 28 patients complained of drug-related side-effects of various kinds, principally nausea, these were usually mild, present at the beginning of treatment and disappeared spontaneously in spite of continued metergoline administration over a prolonged period. No patient stopped treatment because of side-effects. Laboratory parameters also stayed within normal levels and there was no evidence of any alterations in the ECG. It is concluded, therefore, that metergoline is a well-tolerated as well as an effective ergolinic compound for use in those patients in whom prolonged treatment with a prolactin-lowering drug is considered necessary.
Collapse
|